Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

In-vivo CRO Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview: 

The global in-vivo CRO market size reached US$ 4.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 6.87 Billion by 2027, exhibiting a growth rate (CAGR) of 8.30% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

In-vivo contract research organizations (CROs) are institutions that conduct extensive biopharmaceutical research on a contractual basis. They support pharmaceutical and biotechnology companies in formulating effective drugs, vaccines, and medical devices by providing outsourcing services. As compared to in-vitro CRO, in-vivo CRO deals with the research performed within the living organism and conducts human clinical trials to assess the safety and efficacy of the drugs instead of organizing examinations on removed cells and tissues. They aid research institutions in managing complex medical testing, developing effective medications at minimal costs, and optimizing workflow by avoiding delays caused by hiring, fundraising, and clinical preparations. As a result, in-vivo CRO finds extensive application in pain management, oncology, and treating central nervous system (CNS) injuries and other disorders. Currently, they are bifurcated into rodent- and non-rodent-based types.

In-vivo CRO Market Trends:

The increasing prevalence of various cardiovascular ailments, especially amongst the geriatric population, and the growing need for effective medications and novel oncology-based therapies for diagnosis and treatment are primarily driving the market growth. Additionally, the rising demand for clinical-scale manufacturing of active pharmaceutical ingredients (APIs) by contract research, development, and manufacturing organizations (CRDMOs) and the shifting inclination toward biosimilars over format monoclonal antibodies are acting as other growth-inducing factors. Furthermore, the fueling health concerns have prompted biotechnology companies to engineer effective novel vaccines in collaboration with CRO, especially during the COVID-19 pandemic, which is contributing to the market growth. Moreover, the extensive utilization of in-vivo CRO to perform toxicology and pharmacokinetic studies during preclinical activities is impelling the market growth. Apart from this, the advent of bioequivalence, rapid growth in generics, ongoing patent expirations, and continuous research and development (R&D) activities to engineer personalized medicines are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global in-vivo CRO market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, GLP type and indication.

Breakup by Type:

  • Rodent
    • Rats
    • Mice
    • Others
  • Non-Rodent
     

Breakup by GLP Type:

  • Non-GLP
    • In House
    • Outsourcing
  • GLP Toxicology
    • In House
    • Outsourcing
       

Breakup by Indication:

  • Autoimmune/Inflammation Conditions
    • Rheumatoid Arthritis
    • Multiple Sclerosis
    • Osteoarthritis
    • Irritable Bowel Syndrome
    • Others
  • Pain Management
    • Chronic Pain
    • Acute Pain
  • Oncology
    • Blood Cancer
    • Solid Tumor
    • Others
  • CNS Conditions
    • Epilepsy
    • Parkinson’s Disease
    • Huntington’s Disease
    • Stroke
    • Traumatic Brain Injury
    • ALS
    • Muscle Regeneration
    • Others
  • Diabetes
  • Obesity
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Charles River Laboratories International Inc., Evotec SE, ICON plc, Iris Pharma (Abionyx Pharma), Labcorp Drug Development (Laboratory Corporation of America Holdings), North American Science Associates LLC, Parexel International Corporation, Pharmaceutical Product Development Inc. (Thermo Fisher Scientific Inc.), Pronexus Analytical AB, Syneos Health and WuXi AppTec.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Type, GLP Type, Indication, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Charles River Laboratories International Inc., Evotec SE, ICON plc, Iris Pharma (Abionyx Pharma), Labcorp Drug Development (Laboratory Corporation of America Holdings), North American Science Associates LLC, Parexel International Corporation, Pharmaceutical Product Development Inc. (Thermo Fisher Scientific Inc.), Pronexus Analytical AB, Syneos Health and WuXi AppTec.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global in-vivo CRO market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global in-vivo CRO market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the GLP type?
  • What is the breakup of the market based on the indication?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global in-vivo CRO market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global In-vivo CRO Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Type
    6.1    Rodent
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 Rats
           6.1.2.2 Mice
           6.1.2.3 Others
        6.1.3 Market Forecast
    6.2    Non-Rodent
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by GLP Type
    7.1    Non-GLP
        7.1.1 Market Trends
        7.1.2 Key Segments
           7.1.2.1 In House
           7.1.2.2 Outsourcing
        7.1.3 Market Forecast
    7.2    GLP Toxicology
        7.2.1 Market Trends
        7.2.2 Key Segments
           7.2.2.1 In House
           7.2.2.2 Outsourcing
        7.2.3 Market Forecast
8    Market Breakup by Indication
    8.1    Autoimmune/Inflammation Conditions
        8.1.1 Market Trends
        8.1.2 Key Segments
           8.1.2.1 Rheumatoid Arthritis
           8.1.2.2 Multiple Sclerosis
           8.1.2.3 Osteoarthritis
           8.1.2.4 Irritable Bowel Syndrome
           8.1.2.5 Others
        8.1.3 Market Forecast
    8.2    Pain Management
        8.2.1 Market Trends
        8.2.2 Key Segments
           8.2.2.1 Chronic Pain
           8.2.2.2 Acute Pain
        8.2.3 Market Forecast
    8.3    Oncology
        8.3.1 Market Trends
        8.3.2 Key Segments
           8.3.2.1 Blood Cancer
           8.3.2.2 Solid Tumor
           8.3.2.3 Others
        8.3.3 Market Forecast
    8.4    CNS Conditions
        8.4.1 Market Trends
        8.4.2 Key Segments
           8.4.2.1 Epilepsy
           8.4.2.2 Parkinson’s Disease
           8.4.2.3 Huntington’s Disease
           8.4.2.4 Stroke
           8.4.2.5 Traumatic Brain Injury
           8.4.2.6 ALS
           8.4.2.7 Muscle Regeneration
           8.4.2.8 Others
        8.4.3 Market Forecast
    8.5    Diabetes
        8.5.1 Market Trends
        8.5.2 Market Forecast
    8.6    Obesity
        8.6.1 Market Trends
        8.6.2 Market Forecast
    8.7    Others
        8.7.1 Market Trends
        8.7.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Charles River Laboratories International Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Evotec SE
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    ICON plc
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Iris Pharma (ABIONYX Pharma)
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
        14.3.5    Labcorp Drug Development (Laboratory Corporation of America Holdings)
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 SWOT Analysis
        14.3.6    North American Science Associates LLC
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
        14.3.7    Parexel International Corporation
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 SWOT Analysis
        14.3.8    Pharmaceutical Product Development Inc. (Thermo Fisher Scientific Inc.)
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
        14.3.9    Pronexus Analytical AB
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
        14.3.10    Syneos Health
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    WuXi AppTec
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials

List of Figures

Figure 1: Global: In-vivo CRO Market: Major Drivers and Challenges
Figure 2: Global: In-vivo CRO Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: In-vivo CRO Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: In-vivo CRO Market: Breakup by Type (in %), 2021
Figure 5: Global: In-vivo CRO Market: Breakup by GLP Type (in %), 2021
Figure 6: Global: In-vivo CRO Market: Breakup by Indication (in %), 2021
Figure 7: Global: In-vivo CRO Market: Breakup by Region (in %), 2021
Figure 8: Global: In-vivo CRO (Rodent) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: In-vivo CRO (Rodent) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: In-vivo CRO (Non-Rodent) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: In-vivo CRO (Non-Rodent) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: In-vivo CRO (Non-GLP) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: In-vivo CRO (Non-GLP) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: In-vivo CRO (GLP Toxicology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: In-vivo CRO (GLP Toxicology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: In-vivo CRO (Autoimmune/Inflammation Conditions) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: In-vivo CRO (Autoimmune/Inflammation Conditions) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: In-vivo CRO (Pain Management) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: In-vivo CRO (Pain Management) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: In-vivo CRO (Oncology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: In-vivo CRO (Oncology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: In-vivo CRO (CNS Conditions) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: In-vivo CRO (CNS Conditions) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: In-vivo CRO (Diabetes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: In-vivo CRO (Diabetes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: In-vivo CRO (Obesity) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: In-vivo CRO (Obesity) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: In-vivo CRO (Other Indications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: In-vivo CRO (Other Indications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: North America: In-vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: North America: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: United States: In-vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: United States: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Canada: In-vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Canada: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Asia-Pacific: In-vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Asia-Pacific: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: China: In-vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: China: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Japan: In-vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Japan: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: India: In-vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: India: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: South Korea: In-vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: South Korea: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Australia: In-vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Australia: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Indonesia: In-vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Indonesia: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Others: In-vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Others: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Europe: In-vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Europe: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Germany: In-vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Germany: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: France: In-vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: France: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: United Kingdom: In-vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: United Kingdom: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Italy: In-vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Italy: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Spain: In-vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Spain: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Russia: In-vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Russia: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Others: In-vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Others: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Latin America: In-vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Latin America: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Brazil: In-vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Brazil: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Mexico: In-vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Mexico: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Others: In-vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Others: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Middle East and Africa: In-vivo CRO Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Middle East and Africa: In-vivo CRO Market: Breakup by Country (in %), 2021
Figure 78: Middle East and Africa: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Global: In-vivo CRO Industry: SWOT Analysis
Figure 80: Global: In-vivo CRO Industry: Value Chain Analysis
Figure 81: Global: In-vivo CRO Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: In-vivo CRO Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: In-vivo CRO Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: In-vivo CRO Market Forecast: Breakup by GLP Type (in Million US$), 2022-2027
Table 4: Global: In-vivo CRO Market Forecast: Breakup by Indication (in Million US$), 2022-2027
Table 5: Global: In-vivo CRO Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: In-vivo CRO Market: Competitive Structure
Table 7: Global: In-vivo CRO Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4